Investor Home

Corporate Profile

Apricus is committed to developing sexual health therapies in areas of high unmet needs. We have disciplined leadership focused on execution and are driving near-term shareholder value through regulatory approval, commercialization and partnering initiatives.

Recent Newsmore >
DateTitle
12/01/16Apricus Biosciences Receives Nasdaq Compliance Notice
Company Intends to Request Hearing SAN DIEGO, Dec. 01, 2016 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that on November 30, 2016, the Company received notice from the Nasdaq Listing Qualifications Staff (the “Staff”) that due to the Company’s non-compliance with the $35 million market value of listed securities (“MVLS”) requirement, the Company was subject to delisting unl... 
11/29/16Apricus Biosciences to Present at the 9th Annual LD Micro Main Event
SAN DIEGO, Nov. 29, 2016 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that Richard Pascoe, Chief Executive Officer, will present at the 9th Annual LD Micro Main Event on Thursday, December 8, 2016, at 11:30 a.m. Pacific Time.  The conference will be held at the Luxe Sunset Hotel, in Los Angeles, California.  Mr. Pascoe will provide an update on the Company’s strategy and deve... 
11/18/16Apricus Biosciences Provides Update on Vitaros NDA Following Receipt of FDA Feedback
Apricus Re-Affirms Plans to Re-Submit Vitaros U.S. NDA SAN DIEGO, Nov. 18, 2016 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that it has received feedback in response to its previously announced Type B Meeting request to the U.S. Food and Drug Administration (FDA).  The purpose of the FDA meeting request was to confirm Apricus’ strategy for addressing the deficiencies contai... 
Event Calendarmore >
December 2016?
Calendar Help
This calendar contains six months of past and future company related information, which may include press releases, SEC filings, calendar events and more. Dates containing information are indicated by a colored background. You may hover your mouse over a date that contains an event to reveal the event or events taking place on that day including a link to additional information. This calendar requires JavaScript to be installed and activated on your browser.
Calendar Icon Legend:
Analyst Meeting
Conference
Conference Presentation
Corporate Conference Call
Custom Events
Earnings Conference Call
Earnings Release
Financial Reports
Mergers & Acquisition Announcement
Guidance Announcement
Other Corporate
Sales Call/Presentation
Sales Release
Shareholders Meeting
News Release
SEC Filings
Presentations
52 Week High
Today
SMTWTFS
-4-3-2-1123
45678910
11121314151617
18192021222324
25262728293031
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever Apricus Biosciences, Inc. posts new information to the site. Just enter your e-mail address and click Submit.